Clinical Trials Logo

Hyponatremia clinical trials

View clinical trials related to Hyponatremia.

Filter by:

NCT ID: NCT06277336 Not yet recruiting - Hyponatremia Clinical Trials

Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD

ESCAPE
Start date: February 2024
Phase: N/A
Study type: Interventional

Hyponatremia is a common electrolyte imbalance which often results from hormonal disregulation. The study aims to investigate whether the apelin hormone, which plays a role in regulating salt and water balance in the body, can be used to treat hyponatremia. The study will involve healthy volunteers who will be given a medication that causes their bodies to retain water, thus inducing a temporary hyponatremia state. The researchers will measure the volunteers' blood and urine electrolyte levels to see how these are influenced by apelin administration. As comparison, the same measurements will be done in volunteers dosed with placebo instead of apelin. The researchers believe that apelin may be able to help to correct hyponatremia by increasing urine output. If the study focused in the healthy volunteers population is successful, the investigators will assess the effect of apelin administration in patients with chronic hyponatremia. The study's hypothesis is that intravenous apelin will increase urinary excretion and sodium levels in healthy participants with artificially induced hyponatremia.

NCT ID: NCT06171100 Recruiting - Hyponatremia Clinical Trials

Low-dose Tolvaptan for Inpatient Hyponatraemia.

Start date: March 15, 2024
Phase:
Study type: Observational

This is a retrospective cohort study to assess the safety and efficacy of low first dose of Tolvaptan and low or standard second dose of Tolvaptan in patients with moderate to severe hyponatraemia associated with SIADH not responding to conservative means of hyponatraemia management. Patients are treated as part of standard clinical care. There is growing evidence that treating patients with SAIDH induced hyponatraemia using a low dose of Tolvaptan with 7.5mg (below licensed lowest 15mg daily dose). This is the largest study to date and seeks to validate the efficacy and safety or this lower than approved dose of Tolvaptan in patietns who only need a first dose but also in patients who need a second low or srandard dose of Tolvaptan.

NCT ID: NCT06109532 Recruiting - Inflammation Clinical Trials

Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation.

HINDIP
Start date: January 1, 2016
Phase:
Study type: Observational [Patient Registry]

Prospective cohort study in patients with newly diagnosed dengue infection at Hospital Posadas in Argentina, between January 1, 2016, and November 1, 2023. Diagnosis was confirmed by IgM serology or PCR. Hyponatremia was defined as serum sodium concentration ≤135 mEq/L.

NCT ID: NCT06037928 Recruiting - Critical Illness Clinical Trials

Plasma Sodium and Sodium Administration in the ICU

Start date: September 4, 2023
Phase:
Study type: Observational

Patients in the Intensive Care Unit often present with low levels of plasma sodium and are therefore often administered high amounts of sodium, both as an additive to intravenous glucose solutions and as a constituent of various drugs and infusion fluids. Recent findings question the benefit of these large quantities of sodium and raise the question whether the individual physician takes the total sodium administration into account when sodium additives are prescribed. It can also be suspected that sodium prescription differs significantly between physicians.

NCT ID: NCT06020495 Not yet recruiting - Hyponatremia Clinical Trials

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia: a Multicenter Open-label Randomized Controlled Trial

DASSOH
Start date: January 1, 2024
Phase: Phase 3
Study type: Interventional

ICU patients with severe hyponatremia and a high risk of rapid SNa overcorrection.

NCT ID: NCT06013800 Recruiting - Hyponatremia Clinical Trials

Hyponatremia Volume Status Analysis by Point-of-care Ultrasound

Vostaus
Start date: October 1, 2023
Phase:
Study type: Observational

This observational study aims to analyze the time of correction of hyponatremia in patients within an internal medicine ward. The researchers will assess volume status using both clinical evaluation and point-of-care ultrasound. Patients will be categorized based on whether they have the same volume status determined clinically and by ultrasound or a different status between the two methods. By tracking sodium levels daily until normalization, the study will compare the time of hyponatremia correction between the two groups.

NCT ID: NCT05973045 Recruiting - Post-operative Pain Clinical Trials

Investigation of the Effect of Distention Medium Temperature on Image Quality, Hyponatremia Risk, and Post-operative Pain in Operative Hysteroscopy

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Minimally invasive applications are seen as the gold standard in today's gynecology practice and are frequently preferred by both patients and physicians. Less pain, shorter hospital stays, and better cosmetic results brought about by minimally invasive applications further increase their preference. One of these approaches is hysteroscopic interventions. Although hysteroscopy is a well-defined method, current research has focused on further reduction of pain. One of these methods is to warm the distention media at body temperature. theTaim of this study was to examine the effect of distention medium temperature on image quality, hyponatremia risk, and post-operative pain in operative hysteroscopy.

NCT ID: NCT05815550 Completed - Delirium Clinical Trials

Delirium Related to Proton Pump Inhibitors Use

Start date: February 9, 2022
Phase:
Study type: Observational

Delirium is a frequent and severe condition, especially in old adults. Its occurrence is due to a drug in 30% of cases. In 2009, the French national health authority (Haute Autorité de Santé) mentioned proton pump inhibitors (PPIs) among the drugs causing delirium. Most reports of delirium associated with PPI use in the literature are due to severe hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion. However, a few case reports have described the occurrence of delirium PPI without hyponatremia related to PPI use. In 2016, a prospective observational study including 675 old adults found an association between PPI use and the occurrence of delirium. Evidence linking delirium and PPI use is thus scarce. By using data from the pharmacovigilance database of the World Health Organization (WHO), the investigators aim to describe the characteristics of delirium reports in which PPI were suspected to be involved, and to evaluate the association between PPI use and delirium, and the impact of hyponatremia in this association by performing a disproportionality analysis.

NCT ID: NCT05692726 Recruiting - Clinical trials for Non-hypervolemic Hyponatremia

Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational Trial

EvenT
Start date: October 15, 2022
Phase:
Study type: Observational

To assess quantitatively the evolution over time of electrolyte-free water clearance and electrolyte mass balance in patients with non-hypervolemic hypotonic hyponatremia

NCT ID: NCT05542056 Recruiting - Clinical trials for Thiazide-induced Hyponatremia (TIH)

Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia

PROPHECY
Start date: November 11, 2022
Phase:
Study type: Observational

Thiazides and thiazide-like diuretics are one of the five major classes of antihypertensive drugs. This study is to investigate whether urinary PGE2 concentration at baseline (prior to thiazide initiation) is associated with the development of TIH within the first four weeks of treatment.